RNA signature analysis showed that ACC mRNA was increased in ccRCC, and further prognosis analysis displayed increased ACC protein was a poor survival for ccRCC 17, which was consistent with our result. This evidence concerns the gene ACACA and nonpapillary renal cell carcinoma.